In a person in a steady state the set of values obtained for a test carried out on a series of samples will show fluctuation about a value (the setting). In practice a single test value is usually taken as an estimate of the setting. The general consequences of this approximation are discussed in relation to the various uses of data in diagnosis, and illustrated for the common measurements of clinical chemistry. The magnitude of these consequences depends on the proportion of the total variation in a group of persons which is caused by these fluctuations in the person-within-person variation (Varwz). When the proportion is high the aim should be to reduce Varwp. When Varwp is high because of analytical error, then improved analytical technique or replicate analysis is required. Otherwise standardised techniques and conditions for venepuncture or, as a last resort, repeated samplings are necessary. These problems are discussed in relation to the detection of hypokalaemia.
SUMMARY In a person in a steady state the set of values obtained for a test carried out on a series of samples will show fluctuation about a value (the setting). In practice a single test value is usually taken as an estimate of the setting. The general consequences of this approximation are discussed in relation to the various uses of data in diagnosis, and illustrated for the common measurements of clinical chemistry. The magnitude of these consequences depends on the proportion of the total variation in a group of persons which is caused by these fluctuations in the person-within-person variation (Varwz) . When the proportion is high the aim should be to reduce Varwp. When Varwp is high because of analytical error, then improved analytical technique or replicate analysis is required. Otherwise standardised techniques and conditions for venepuncture or, as a last resort, repeated samplings are necessary. These problems are discussed in relation to the detection of hypokalaemia.
Most clinical chemistry laboratories send to clinicians a report form which contains no more than the value obtained for a particular test and (usually) a reference range for that test. The result is a discussion on the ward, such as-Question: What is Mr Jones's 'potassium'? Answer: Low, 2·5 (Sir!). Most persons recognise the uncertainty about the reported value because ofanalytical error and because of 'real' variation in the value in a person from time-to-time. Nevertheless, in practice the reported value is often regarded as 'representative' of that person so that an 'abnormal value' would indicate an 'abnormal person'-that is, Mr Jones has hypokalaemia.
Some variables are known to fluctuate with a predictable pattern (a rhythm); an example is the diurnal rhythm of the plasma cortisol concentration (Weitzman et al., 1971) . However, there is no clear rhythm for most variables measured in clinical practice, but only random variation about a value which can be regarded as the value most characteristic of the individual (the setting).
The range of single test values which may be observed in an individual in a steady state is determined by the setting and by the magnitude of the fluctuations. Setting or fluctuations or both could be abnormal in disease.
Consequences of interpreting single test values rather than settings
The consequences can be considered in relation to three 'uses' of biochemical values in diagnosis.
The first use is the positioning (ranking or grading) of a patient in relation to a reference range. The aim is to compare a person (the patient) with a group of persons, but what is done is to compare a value with a group of values. What we should do is to compare a setting with a group of settings, and our failure to do so has several consequences. Because an individual's value fluctuates from time-to-time, a patient could have a 'normal' value on some occasions and an 'abnormal' one on others. If a group of patients is measured on several occasions the average value and the number of abnormal persons could be the same on each occasion, but different individuals could be 'abnormal' on different occasions. The number of abnormal values would not give a reliable estimate ofthe number ofabnormal persons (that is, abnormal settings).
The second use of biochemical values is in the detection of specific disease, and this is based on the differences of the distributions of test values in healthy persons and in patients known to have a particular disease. The greater the separation (discrimination) between these two distributions the 49 more useful the test will be in allocating a 'new' patient to one of the two groups. The greater the fluctuation in each person, the wider will be each distribution, and the less the discrimination between the groups. In this case values will be less useful than settings in allocating persons to groups.
The third use of biochemical values is in the detection of a change in a test variable as a result of treatment or progress of the disease. Clearly what is required is detection of a change in the setting. A change in a test value would have to be distinguished from spontaneous fluctuation before it could be attributed to treatment or progress of the disease.
If single values have these disadvantages compared with settings, we need to know just how big the disadvantages are and what we can do about them.
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esting for the tests that are commonly made in clinical chemistry.
Such tests have been made on several occasions ;. each of a group of healthy persons Harris et al., 1970; Williams et al., 1970 ' Statland et al., 1973 Bokelund et al., 1974; Statlanc et al., 1974; Winkel et al., 1974; Statland et al.. 1976) . Some of the results were summarised by Harris (1974) . The variances were 3·66 mmol/l for sodium, 0·08 rnmol/l for potassium, 5·07 mrnol/l for chloride, 0·0046 mrnol/l for magnesium, 30·3 J-tm/I for AST, 2·51 g/I for total protein, and 10'2m g/loo ml for cholesterol; these can be recalculatec to yield the relative magnitude of within-person am between-person variances, taking the total variance as 100 %. Some of the results are shown in Fig. 2 
Components of variation of test values
A comprehensive study of these components would require a series of test values in each of a group of persons, so that the setting and fluctuations can be defined for each person. This would be a major undertaking and, in practice, few measurements are made in each of a group of persons. An analysis of variance gives an estimate of the components for the group, that is it gives the variation in the settings, and the average fluctuations about the setting for the group. The technique does not give the setting and fluctuations in each individual. The components of variance are shown in Fig. 1 . Throughout the text variation will usually be given in terms of variance since variances can be added. It is, of course, misleading to regard standard deviation as even approximately additive (SD = VVar). The between-person variance (Varp-p) ( Fig. 1 ) is the variation in the settings between persons and the within-person variance (Varwp) is a measure of the fluctuations. If we knew the relative magnitude of Varp-p and Varwp for some of the tests, we could assess the effect of fluctuations on the interpretation of the test values. This would be particularly inter- Fig. 2 The relative contribution of within-person variability and between-person variability to total variance in healthy persans of same commonly measured plasma constituents (calculated fram data of Harris, 1974) .
In healthy persons most of the variance for cholesterol is between persons rather than within the person and a single cholesterol value is a reasonably reliable guide to the setting of cholesterol in thai person. However, in healthy persons much of the variance in plasma sodium and plasma potassium is due to variation within the person so that a single value is an unreliable guide to that person's setting for plasma sodium or plasma potassium. We can use these results to investigate the effect of Var w» on the interpretation of the test values.
One consequence was that if each of a group of Abnormal then the first few times that the population is measured, almost entirely different groups of persons will be detected as abnormal, and the total number of persons abnormal on at least one occasion, increases rapidly with repeated testing. Another consequence of the presence of withinperson variability is that in the comparison of two populations (for example, normal and diseased), the proportion of abnormal values in the disease group is not the proportion of abnormal persons in the disease group. Figure 4 persons was tested on several occasions, then the number of persons outside a particular value (for example, less than the lower limit of normal) would be the same on each occasion, but different persons would be 'abnormal' on different occasions. The greater the number of times the test was repeated and the greater the within-person variation (Varwi-) then the greater the proportion of the population who would be abnormal at one time or another.
A. Kirwan (personal communication) has calculated for healthy persons the relationship between the number of testings and the cumulative proportion of the population who would be below the lower limit of normal (mean -2 SD) according to the proportion of the total variance (Varror) which is within-person variance (Varwj-). The results are shown in Fig. 3 . After a single test 2·25 %of a group o 1 2 3 4 5 No. of measurements 6 Fig. 4 The percentage of abnormal values and of abnormal persons according to the ratio of SDwp to SDT, when the disease group has the same SD as the normal group but a mean value which is 1 SD lower; Fig. 3 The cumulative percentage ofpopulation with a low value for a variable (less than mean -2SD) according to the number of separate measurements made on the population and according to the proportion of the total variance which is within-person variance (calculated from data of Harris, /974). of healthy persons would have abnormal values and if all the variation is between-person variance only these same persons would be abnormal each time the population was tested. On the other hand, where the major proportion of the variance is within-person variance (for example, plasma sodium or potassium), in which the variance of values in the disease group is the same as in the normal group, but the mean is one standard deviation lower. At one extreme, for a test where all the variance is between persons, then the number of abnormal values and the number of abnormal persons will be the same (15 %). At the other (ridiculous) extreme where all the variance is within person then there will still be 15%of abnormal values, but the number of abnormal patients will be 100%. Figure 4 shows how the percentage of abnormal persons increases as the proportion of total variance due to within-person variance increases. 
123456
Samples within the person. The possible sources of preinstrument error may be well known for a particular test, such as the effect of venepuncture technique on plasma potassium and plasma calcium. 'True" biological variation within the person may have a well defined rhythm-for example, plasma cortisol. Clearly the diagnostic usefulness of the test value will improve if these sources of variation are avoided or minimised by standardising conditions of time of day, posture, and venepuncture technique. But standardisation is not easy to achieve in patients.
If the fluctuations are caused by true intraperson variability then they can be reduced by considering the average of the values for replicate samples. The effect of replications on the variance and standard deviation can be calculated. Replicate samples will reduce the within-person variation (both VarA and VarWP-A) and will reduce the normal range by an amount which depends on how much of the Vartot is due to Varwp. This narrowing of the normal range with replication of samples is not generally appreciated, but can be important when a patient is being repeatedly tested because he is found to have a 'borderline' possibly abnormal test value. An example would be a patient who might have hyperparathyroidism but whose plasma calcium level fluctuates from time-to-time, so that sometimes it is abnormal and sometimes it is normal (Fig. 6 ). The
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The source of intraperson variability 100 Some of the consequences of variation within the person have been discussed, but what is the source of this variation and what can we do about it? Figure 1 shows that the within-person variability ismade up of analytical error and the non-analytical within-person variability which is made up of pre-instrument error and 'true', 'biological', within-person variability. The relative magnitude of these two components of Varwp is shown in Fig. 5 for some common tests Fig. 5 The relative contribution of the components of variance to the total variance in healthy persons of some commonly measured plasma constituents (calculated from data of Harris, 1974) .
(as calculated from the data of Harris, 1974) . The proportion of VarTOT due to Varwp is the same for sodium and potassium but within-person variability is largely due to analytical error (varx) in the case of sodium, and to pre-instrument error or withinperson variability (Varwr-A)in the case of potassium.
If Varwp is caused by analytical error, then it can be reduced by improving the analytical technique (possibly approaching the limit of the technique) or by replicating analyses on a given sample which is rarely done, although many laboratories have the capacity to do this at least on selected samples. However, the major source of within-person variability may be non-analytical, either caused by preinstrument error or by 'true' biological variation variation could in part be owing to variable posture and venepuncture technique, which should of course be standardised if possible, or taken into account by standardising the plasma calcium value for the plasma albumin. I am not sure how these results would be assessed in practice, but one way would be to calculate the mean of all results as each result becomes available. This running mean will give a better estimate of the setting, assuming that the patient remains in an unchanging steady state with no long-term trends. The running mean should be compared with a narrowing normal range since the Yarwp is decreasing with the number of replicates. This is a simple approach to the problems; a much more detailed approach has been discussed by Harris (1976) .
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deviation was greater and the mean was lower. The number of patients with hypokalaemia (a plasma potassium less than 3·6 rnmol/l) was similar on the two occasions (11 and 15) and was close to the number predicted from the differences of the distributions of values in the patients and the controls. However, the surprise finding was that only a few patients (four) who had a low plasma potassium on the first occasion also had a low value on the second occasion. This discrepancy can be due only to a large within-person variability. Table 2 shows Table 2 The components of variance (as SD) ofplasma potassium in healthy subjects and the patients with heart failure. The analysis allows an assessment of settings and fluctuations in the two groups Table 1 The mean and standard deviation of single measurements plasma potassium immolll') on one occasion in a group of healthy persons and on two occasions in 75 patients with heart failure, and the number of low values (less than 3'6 mmolli) in the patients with heart failure
Abnormal values and abnormal people
The aspect consequence of intraperson variability whichhas most bothered me recently is the increasing discrepancy between normal values and abnormal patients as the within-person variance increases (Fig. 4) . My colleagues, Dr Davidson and Dr Burkinshaw, and I came across this problem recently in a study of hypokalaemia in patients with heart failure taking digoxin and diuretics. As a preliminary to a comparison of several treatments, each of 75 patients had a sample taken on two occasions a month apart. All blood samples were taken by the same person and, although a tourniquet was sometimes necessary, hand pumping was avoided. Each patient attended at the same time of day on both occasions, and none took any diuretic or potassium supplements that day until the blood sample had been taken. The values of plasma potassium in these 75 patients are shown in Table 1 %Low I~It he components of variance calculated in terms of standard deviation for the patients and the control group (the analytical standard deviation has been taken as 0'07 mmol/l), A major difference between the patients and the controls was that the nonanalytical within-person variability was much greater in the patients than in the controls. This could be because of an increase in the pre-instrument error, or true 'biological' within-person variability, or both. It is not possible to say which it is in this case, but difficult venepunctures will be more common in patients who have been much studied than in healthy controls. The between-person standard deviation SDpp was similar in the two groups and these values together with the mean values give the distribution of settings in the two groups. A comparison of the distributions of settings suggests that there are 12 patients with settings less than the 'lower limit of normal' of the settings in healthy persons. (It is pure chance that this figure is similar to the number of low values in the patients). It should be emphasised that is is not possible from these results to say which 12 persons have the low settings, since we do not know the setting for each person but only the distribution of the settings as defined by the analysis of variance. Thus, when within-person variation is large, although we can clearly define which values are 'abnormal' and which patients they come from, the incidence of abnormal patients is more difficult to define and it is not possible to say which patients are abnormal.
These limitations further emphasise the importance of reducing Varwp by standardising the conditions of venepuncture. It should be emphasised that samples were taken from our patients with all these points in mind and the Varwp we found is almost certainly no more, and is probably less, than in routine cardiology clinics.
Conclusion
When a test is made repeatedly in a person in a steady state the result will be a set of values which can be regarded as fluctuating about an average value (the setting). It is the setting which is characteristic of the patient. A single test value may deviate considerably from the setting.
The consequences of the fluctuations about the setting (Varws) are defined and are illustrated by published data for the common tests in healthy persons. The Varwp and therefore the consequences are probably even greater in patients. We need to define those tests for which within-person variability is large, and we should make this assessment in 'real-life' but standardised and defined clinical conditions, rather than in idealised experimental conditions. An important consequence is that abnormal values do not necessarily detect the abnormal persons. When the within-person variability is large because of analytical error it can be reduced by replicate analyses of the samples. Every effort should be made to reduce within-person variability from pre-instrument error by standardising the conditions for sample collection and transport. Finally, we are left with biological withinperson variability. The ultimate would be to define this in the individual by measuring so many samples that one could define not only the person's setting but also the magnitude of the fluctuations (see Harris, 1976) . Either or both of these could change in disease.
